Endeavor

New Treatment Reduces Need for Blood Transfusions for Patients with Certain Blood Cancers, Study Shows

Almost 40% of patients with lower risk myelodysplastic syndromes achieved eight-week transfusion independence with imetelstat, study shows

Already Approved Drug Shows Promise in Patients with MDS/MPN Overlapping Syndromes

Moffitt launched trial investigates myelofibrosis drug in rare patient population

Looking at Guided Radiation for Triple-Negative Breast Cancer

A new study personalizes radiation therapy doses for patients based on their tumor profile

Using Contemporary Data to Better Classify Blood Clot Risk in Polycythemia Vera Patients

Study shows age is less of a factor than medical history when it comes to risk for thrombosis

Special Recognition for the Specialty Pharmacy

New accreditations open doors to reduce medication costs for patients

Moffitt Launches Podcast Focused on Our Patients

PEP Talks features inspirational life-changing stories around cancer

Not Everyone Has Access to Quality Cancer Surgery, But Global Commission Aims to Change That

Lancet Oncology Commission on Global Cancer Surgery lays out a roadmap to address lack of access among patients worldwide

Save the Body, Lose the Soul

As a Jehovah’s Witness, Naomi Burgess refuses to accept blood products. When she was diagnosed with leukemia, she faced the ultimate test of her faith.

Bioengineering: A New Frontier in Cancer Research

The launch of Moffitt’s Bioengineering Department brings novel tools to the fight against cancer